pharmaphorum

DECEMBER 2, 2022

Enrolling for clinical trials has become more challenging in recent years, with trial competition, increasingly complex protocols, and precision medicine targeting more niche patient populations. These potential study risks can lead to costly deviations and amendments, enrolment difficulties, and reduced patient compliance. March 2022.

Competition 96

Competition Leads Patients Electronics 96

pharmaphorum

JULY 27, 2022

Latest UK Life Sciences Competitive Indicators “ought to ring alarm bells across Government,” says ABPI. Richard Torbett, chief executive at the Association of the British Pharmaceutical Industry (ABPI) said Life Sciences Competitive Indicators (LSCI) data published last week “ought to ring alarm bells across Government”.

Government 92

Government Recruitment Medicine Patients 92

pharmaphorum

JANUARY 9, 2023

Compared to major primary care markets of the late 1990s/early 2000s, specialty care markets see more and earlier competitive launches, and the market share achieved by each launch after is progressively reduced. Research and development spend by major companies has increased 44% since 2016.

Medicine 86

Medicine Healthcare Healthcare Pharma 86

Clarivate

JANUARY 30, 2023

As we note in our white paper, a 2016 European Commission report suggested that only between 10 to 50% of patents declared to be essential in the ETSI actually are. Although the change in policy was presented by the agencies as promoting innovation and competition, it may lead to increased uncertainty and litigation around SEPs.

Marketing 52

Marketing Management Education Competition 52

Clarivate

OCTOBER 26, 2021

Despite the turbulent economic landscape, the number of patents in force grew to over 15m worldwide in 2020, with an average 7% annual growth 2016-2019. When rights are lost, the rest of the market can capitalize, stripping away years of innovation and competitive advantage – alongside the revenue associated to those rights.

Networking 52

Networking Management Leads Insurance 52

PharmaKinnex

AUGUST 23, 2022

The pharmaceutical industry of 2022 is very different from the space that we all knew in 2012, 2016, or even 2020. Let’s dive into the current state of the pharma industry and learn more about what your team can do to stay ahead of the curve and the competition. The Traditional Pharma Model Isn’t Working – It’s Time to Evolve!

Pharma 52

Pharma Sales Sales Strategy Marketing 52

Clarify Health

MARCH 1, 2023

Placing clinicians at financial risk for controlling health costs and improving quality without equipping them with the tools to do so leads to frustration and disillusionment. This delicate balance taps into physician’s natural competitive tendencies, but bounds these tendencies in shared goals and joint commitment.

Physicians 52

Physicians Prescription Medicine Healthcare 52

Contrarian Sales Techniques

DECEMBER 22, 2020

The lead includes more than 1,000 biotech start-ups created between 2012 and 2016, with a further 500 founded in 2017. According to the World Economic Forum's 2017 Global Competitiveness Report, the Association of Southeast Asian Nations (ASEAN) is on track to become Asia's next economic powerhouse.

Government 52

Government Competition Pharmaceutical Management 52

European Pharmaceutical Review

JULY 4, 2024

2 It was first approved as Fulyzaq in December 2012 and in October 2016, Napo Pharmaceuticals launched the new brand, Mytesi. Prior to joining Fieldfisher, Taly spent four years working as in-house counsel for a leading tech company helping launch products across multiple EU markets. 3 Is two too few? BMB Reports. 2017;50(3):111–6.

Marketing 103

Marketing Food and Drug Administration Medicine Prescription 103

European Pharmaceutical Review

JUNE 24, 2022

The review was impacted by Brexit and the COVID-19 pandemic, which compounded existing issues surrounding high drug pricing and patient access that had been brewing since 2016 and highlighted several shortcomings in the EU’s pharmaceutical system. Maarten has significant competition law experience in a variety of sectors. References.

Pharmaceutical 105

Pharmaceutical Medicine Marketing Competition 105

Sales Talent

FEBRUARY 7, 2020

This pressure is leading to increased base salaries. Linkedin’s 7 Predictions on How Recruiting Will Be Different in 2025 shows that “the demand for recruiting professionals has jumped by 63% since 2016, and we expect that trend to continue.”. To combat this, employers must utilize a three-pronged approach.

Sales 52

Sales B2B Sales Recruitment Marketing 52

pharmaphorum

JUNE 29, 2022

This preference leads to fewer opportunities to prescribe new launches in an environment with fewer face-to-face opportunities, and, for many conditions, gaps and backlogs in screening, diagnosis, and check-up. Launches, therefore, were happening. But were they fulfilling their commercial potential?

Doctors 59

Doctors Medicine Marketing Sales 59

CloserIQ

OCTOBER 10, 2018

They’ve worked with leading clients such as Twitter and Mercedes Benz. Founded 2016. Cybereason’s workplace culture is known to be fast-paced and competitive, with plenty of opportunities for learning. Salsify offers competitive benefits and a flexible vacation plan. Founded 2007. 501-1000 employees. million in funding.

Sales 76

Sales Management Education Marketing 76

Spotio

OCTOBER 26, 2023

Rep satisfaction Finally, sales coaching platforms lead to rep satisfaction. Sales coaching tools will help you coach your reps consistently in an organized and thoughtful way that leads to greater rep success. Just as important, you won’t know which activities lead to desired results. Your reps want to be coached.

Sales Management 52

Sales Management Sales Management Training 52

Evolve Your Success

MAY 23, 2023

With VR simulations, sales reps can now hone their skills in lifelike scenarios, giving them a competitive edge in the field. Osso was founded in 2016. I landed this competitive scholarship at the National Cancer Institute at school. There’s a little bit of a competitive streak in me and a lot of us in sales.

Training 52

Training Medical Sales Medical sales 52

Pharmaceutical Technology

MAY 17, 2023

Obeticholic acid or OCA is a farnesoid X receptor agonist and is marketed by Intercept under the name Ocaliva for use against primary biliary cholangitis, following an approval in May 2016. This results in bile buildup in the liver and can lead to scarring. Bezafibrate is a peroxisome proliferator-activated receptor agonist.

Food and Drug Administration 52

Food and Drug Administration FDA Pharmaceutical Prospecting 52

Clarivate

DECEMBER 14, 2023

IDNs coalesce along Competitive Service Regions As nonprofit IDNs push out from their home markets and for-profit and Catholic IDNs pull back from earlier expansions, distinct competitive service regions with common rivalries are developing across the nation.

Marketing 52

Marketing Healthcare Healthcare Insurance 52

Clarivate

OCTOBER 17, 2024

As California Attorney General from 2011 to 2017, Harris was a forceful opponent of healthcare industry consolidation, both vertical and horizontal, believing that mergers of hospitals, physician groups and insurers would damage competition and raise prices for care.

Healthcare 52

Healthcare Healthcare Government Insurance 52